港股異動 | 創維集團盤中大漲12% 機構唱好+北水加倉
格隆匯1月16日丨創維集團(0751.HK)盤中一度大漲12%,最高報5.43港元有望挑戰階段高價,暫成交2.07億港元,總市值136億港元。根據分部估值法,第一上海給與公司2023年光伏業務估值中樞15倍PE,傳統家電業務估值中樞8倍PE,現代服務業務估值中樞5倍PE,調整創維集團目標價由6.31港元上調11%至7港元,維持買入評級。該行又稱,在雙碳目標和整縣推進政策的雙重利好下,公司將繼續大力發展户用光伏業務,並逐步開拓工商業光伏業務。另外,上週五公司獲南向資金加倉962.00萬股,截止當日收盤,港股通共持有創維集團31609.34萬股。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.